World Specialty Enzymes Market

World Specialty Enzymes Market

This report analyzes the worldwide markets for Specialty Enzymes in Millions of US$. The specific product segments analyzed are Specialty Medical Enzymes, Polymerases, Nucleases, and Other Specialty Enzymes. The specific end-use segments discussed are Pharmaceuticals & Diagnostics, and Research/Biotechnology. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 44 companies including many key and niche players worldwide such as Advanced Enzymes Technologies Limited, Amano Enzyme Inc., Aureozyme Inc., Biocon Ltd., Operational Model of Biocon, Biozyme Laboratories, Danisco, Genencor, Kinetic Biosystems, Inc., Maxygen Inc, Codexis Inc., Novozymes, Seravac Biotech (Pty) Ltd, Specialty Enzymes and Biochemicals Co., and Verenium Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

SPECIALTY ENZYMES MCP-2056
A GLOBAL STRATEGIC BUSINESS REPORT


CONTENTS


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability And Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-2
Product Definitions And Scope Of Study I-3
Specialty Medical Enzymes I-3
Polymerases I-3
Nucleases I-4
Other Specialty Enzymes I-4
Pharmaceuticals/Diagnostic I-4
Research/Biotechnology I-4


II. EXECUTIVE SUMMARY

1. Introduction II-1

2. Global Market Overview II-2

3. Enzymes- A Review II-3
Definition II-3
Introduction II-3
Advantages of Enzymes Compared to Chemical Catalysts II-3
Table 1: Enzymes Market Worldwide (2005 & 2006): Market Share
of Leading Players- Novozymes, Genencol, DSM, BASF and Others
(includes corresponding Graph/Chart) II-4
A Brief History II-4

4. Specialty Enzymes: An Overview II-6
Analysis of Product Segments II-6
Specialty Medical Enzymes II-6
Polymerases II-7
Nucleases II-7
Other Specialty Enzymes II-7

5. Analysis of the End-Use Markets II-8
Pharmaceuticals & Diagnostics II-8
Research/Biotechnology II-8
Other End Use Markets II-8

6. Technology Trends II-9
Protein Engineering Technology II-9
Specialty Enzymes in Industrial Uses II-9
Enzyme Technology in Pig Industry II-9

7. Product Innovations/Introductions II-10
MARDI Develops Taq DNA Polymerase II-10
Stratagene Corporation Commercializes DNA Polymerases II-10
Takara Bio Launches PrimeSTAR HS DNA Polymerase II-10
Verdia and Pioneer Hi-Bred International Develops Glyphosate
-Resistant Crop Trait II-10
Novozymes Creates Lipase Enzyme II-10

8. Recent Industry Activity II-11
Inverness Medical Innovations Acquires BBI Holdings Plc II-11
Helix Biopharma Enters into a Contract with KBI Biopharma II-11
Verenium Enters into Agreement with Bunge Oils II-11
BBI Holdings Acquires Theratase Plc II-11
Danisco to Acquire Stake in South African Firm II-11
Affymetrix to Buy USB Corporation II-12
Diversa Merges with Celunol to Form Verenium Corporation II-12
Diversa Collaborates with BASF II-12
Codexis Expands Collaboration with Royal Dutch Shell to
Develop Super Enzymes II-12
Diversa Enters into a Deal with Syngenta to Develop Enzymes II-12
Genencor Begins Operation at New China Site and Introduces a
New Detergent Enzyme II-12
Verenium Receives $4.6 million For Enzyme Development II-13
Biocon Divests its Enzymes Business to Novozymes II-13
Solexa Signs Agreement with New England Biolabs II-13
Danisco Takes Over Genencor II-13
IBEX Technologies Inks Agreement with Cape Cod and Prozyme II-13

9. Focus on Select Players Worldwide II-14
Advanced Enzymes Technologies Limited (India) II-14
Amano Enzyme Inc. (Japan) II-14
Aureozyme Inc. (USA) II-14
Biocon Ltd. (India) II-15
Operational Model of Biocon II-15
Biozyme Laboratories (UK) II-15
Danisco (Denmark) II-16
Genencor (USA) II-16
Kinetic Biosystems, Inc. (USA) II-17
Maxygen Inc (USA) II-17
Codexis Inc. (USA) II-17
Novozymes (Denmark) II-17
Seravac Biotech (Pty) Ltd (South Africa) II-18
Specialty Enzymes and Biochemicals Co. (USA) II-18
Verenium Corporation (USA) II-18

10. Global Market Perspective II-19
Table 2: World Recent Past, Current & Future Analysis for
Specialty Enzymes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East, and
Latin America Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) II-19

Table 3: World Long-term Projections for Specialty Enzymes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East, and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-20

Table 4: World 10-Year Perspective for Specialty Enzymes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East, and Latin America Markets for Years 2003, 2008 &
2012 (includes corresponding Graph/Chart) II-21

Table 5: World Recent Past, Current & Future Analysis for
Specialty Medical Enzymes by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East,
and Latin America Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2010
(includes corresponding Graph/Chart) II-22

Table 6: World Long-term Projections for Specialty Medical
Enzymes by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East, and Latin America
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) II-23

Table 7: World 10-Year Perspective for Specialty Medical
Enzymes by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East, and Latin America Markets for Years 2003,
2008 & 2012 (includes corresponding Graph/Chart) II-24

Table 8: World Recent Past, Current & Future Analysis for
Polymerases by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East, and Latin
America Markets Independently Analyzed with Annual Sales
Figuresin US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) II-25

Table 9: World Long-term Projections for Polymerases by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East, and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-26

Table 10: World 10-Year Perspective for Polymerases by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East, and Latin America Markets for Years 2003, 2008 &
2012 (includes corresponding Graph/Chart) II-27

Table 11: World Recent Past, Current & Future Analysis for
Nucleases by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East, and Latin America
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) II-28

Table 12: World Long-term Projections for Nucleases by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East, and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-29

Table 13: World 10-Year Perspective for Nucleases by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East, and Latin America Markets for Years 2003, 2008 &
2012 (includes corresponding Graph/Chart) II-30

Table 14: World Recent Past, Current & Future Analysis for
Other Specialty Enzymes by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East,
and Latin America Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2010
(includes corresponding Graph/Chart) II-31

Table 15: World Long-term Projections for Other Specialty
Enzymes by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East, and Latin America
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) II-32

Table 16: World 10-Year Perspective for Other Specialty
Enzymes by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East, and Latin America Markets for Years 2003,
2008 & 2012 (includes corresponding Graph/Chart) II-33

Table 17: World Recent Past, Current & Future Analysis for
Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics
by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East, and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-34

Table 18: World Long-term Projections for Specialty Enzymes
Consumption in Pharmaceuticals & Diagnostics by Geographic
Region- US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East, and Latin America Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) II-35

Table 19: World 10-Year Perspective for Specialty Enzymes
Consumption in Pharmaceuticals & Diagnostics by Geographic
Region - Percentage Breakdown of Dollar Sales for US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East,
and Latin America Markets for Years 2003, 2008 & 2012
(includes corresponding Graph/Chart) II-36

Table 20: World Recent Past, Current & Future Analysis for
Specialty Enzymes Consumption in Research/Biotechnology by
Geographic Region- US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East, and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-37

Table 21: World Long-term Projections for Specialty Enzymes
Consumption in Research/Biotechnology by Geographic Region-
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East, and Latin America Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) II-38

Table 22: World 10-Year Perspective for Specialty Enzymes
Consumption in Research/Biotechnology by Geographic Region -
Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East, and
Latin America Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-39

Table 23: World Recent Past, Current & Future Analysis for
Specialty Enzymes Consumption in Other End-Use Segments by
Geographic Region- US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East, and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-40

Table 24: World Long-term Projections for Specialty Enzymes
Consumption in Other End-Use Segments by Geographic Region-
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East, and Latin America Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) II-41

Table 25: World 10-Year Perspective for Specialty Enzymes
Consumption in Other End-Use Segments by Geographic Region -
Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East, and Latin
America Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-42


III. MARKET

1. The United States III-1
A.Market Analysis III-1
Market Dynamics III-1
Specialty Enzymes Market is Projected to Rise 7% Annually III-1
Specialty Enzymes Form the Leading Enzymes Segment III-1
Pharmaceuticals and Diagnostics Continue to be the Largest
Market III-1
Specialty Medical Enzymes in a Myriad of Novel Applications III-2
Market for Enzymes in Biotechnology III-2
Product Launch III-2
Strategic Corporate Developments III-2
Select Players III-4
Aureozyme Inc. III-4
Genencor. III-5
Kinetic Biosystems, Inc. III-5
Maxygen Inc III-5
Codexis Inc. III-6
Specialty Enzymes and Biochemicals Co. III-6
Verenium Corporation III-6
B.Market Analytics III-7
Table 26: US Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-7

Table 27: US Long-term Projections for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) III-7

Table 28: US 10-Year Perspective for Specialty Enzymes by
Product Segment - Percentage Breakdown of Dollar Sales for
Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-8

Table 29: US Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-9

Table 30: US Long-term Projections for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-9

Table 31: US 10-Year Perspective for Specialty Enzymes by
End-Use Segment - Percentage Breakdown of Dollar Sales for
Pharmaceuticals & Diagnostics, Research/Biotechnology and
Others Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-10

2. Canada III-11
A.Market Analysis III-11
Strategic Corporate Development III-11
B.Market Analytics III-11
Table 32: Canadian Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010(includes corresponding
Graph/Chart) III-11

Table 33: Canadian Long-term Projections for Specialty
Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-12

Table 34: Canadian 10-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-12

Table 35: Canadian Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research / Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-13

Table 36: Canadian Long-term Projections for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-13

Table 37: Canadian 10-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology
and Others Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-14

3. Japan III-15
A.Market Analysis III-15
Product Launch III-15
Amano Enzyme Inc. - A Major Player III-15
B.Market Analytics III-16
Table 38: Japanese Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-16

Table 39: Japanese Long-term Projections for Specialty
Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-17

Table 40: Japanese 10-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-17

Table 41: Japanese Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-18

Table 42: Japanese Long-term Projections for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-18

Table 43: Japanese 10-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research / Biotechnology
and Others Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-19

4. Europe III-20
Market Analysis III-20
Table 44: European Recent Past, Current & Future Analysis
for Specialty Enzymes by Geographic Region - France,
Germany, Italy, UK, Spain, Russia, and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-20

Table 45: European Long-term Projections for Specialty
Enzymes by Geographic Region - France, Germany, Italy, UK,
Spain, Russia, and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-21

Table 46: European 10-Year Perspective for Specialty Enzymes
by Geographic Region - Percentage Breakdown of Dollar Sales
for France, Germany, Italy, UK, Spain, Russia, and Rest of
Europe Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-22

Table 47: European Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-23

Table 48: European Long-term Projections for Specialty
Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-23

Table 49: European 10-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes Polymerases, Nucleases and
Other Enzymes Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-24

Table 50: European Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-25

Table 51: European Long-term Projections for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-25

Table 52: European 10-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology
and Others Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-26

4a. France III-27
Market Analysis III-27
Table 53: French Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-27

Table 54: French Long-term Projections for Specialty Enzymes
by Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) III-28

Table 55: French 10-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-28

Table 56: French Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-29

Table 57: French Long-term Projections for Specialty Enzymes
by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-29

Table 58: French 10-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology
and Others Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-30

4b. Germany III-31
Market Analysis III-31
Table 59: German Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-31

Table 60: German Long-term Projections for Specialty Enzymes
by Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) III-32

Table 61: German 10-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-32

Table 62: German Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-33

Table 63: German Long-term Projections for Specialty Enzymes
by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-33

Table 64: German 10-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology
and Others Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-34

4c. Italy III-35
Market Analysis III-35
Table 65: Italian Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-35

Table 66: Italian Long-term Projections for Specialty
Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-36

Table 67: Italian 10-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-36

Table 68: Italian Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-37

Table 69: Italian Long-term Projections for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-37

Table 70: Italian 10-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology
and Others Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-38

4d. The United Kingdom III-39
A.Market Analysis III-39
Biozyme Laboratories Limited - A Major Player III-39
B.Market Analytics III-40
Table 71: UK Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-40

Table 72: UK Long-term Projections for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) III-41

Table 73: UK 10-Year Perspective for Specialty Enzymes by
Product Segment - Percentage Breakdown of Dollar Sales for
Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-41

Table 74: UK Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-42

Table 75: UK Long-term Projections for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-42

Table 76: UK 10-Year Perspective for Specialty Enzymes by
End-Use Segment - Percentage Breakdown of Dollar Sales for
Pharmaceuticals & Diagnostics, Research/ Biotechnology and
Others Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-43

4e. Spain III-44
Market Analysis III-44
Table 77: Spanish Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-44

Table 78: Spanish Long-term Projections for Specialty
Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-45

Table 79: Spanish 10-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2003, 2008 & 2012(includes
corresponding Graph/Chart) III-45

Table 80: Spanish Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010(includes corresponding
Graph/Chart) III-46

Table 81: Spanish Long-term Projections for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-46

Table 82: Spanish 10-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology
and Others Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-47

4f. Russia III-48
Market Analysis III-48
Table 83: Russian Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-48

Table 84: Russian Long-term Projections for Specialty
Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-49

Table 85: Russian 10-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-49

Table 86: Russian Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-50

Table 87: Russian Long-term Projections for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-50

Table 88: Russian 10-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research / Biotechnology
and Others Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-51

4g. Rest of Europe III-52
A.Market Analysis III-52
Strategic Corporate Development III-52
Select Players III-52
Danisco (Denmark) III-52
Novozymes (Denmark) III-53
B.Market Analytics III-54
Table 89: Rest of Europe Recent Past, Current & Future
Analysis for Specialty Enzymes by Product Segment -
Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2010
(includes corresponding Graph/Chart) III-54

Table 90: Rest of Europe Long-term Projections for Specialty
Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-55

Table 91: Rest of Europe 10-Year Perspective for Specialty
Enzymes by Product Segment - Percentage Breakdown of Dollar
Sales for Specialty Medical Enzymes, Polymerases, Nucleases
and Other Enzymes Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-56

Table 92: Rest of Europe Recent Past, Current & Future
Analysis for Specialty Enzymes by End-Use Segment -
Pharmaceuticals & Diagnostics, Research / Biotechnology and
Others Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-57

Table 93: Rest of Europe Long-term Projections for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research / Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-57

Table 94: Rest of Europe 10-Year Perspective for Specialty
Enzymes by End-Use Segment - Percentage Breakdown of Dollar
Sales for Pharmaceuticals & Diagnostics, Research/
Biotechnology and Others Markets for 2003, 2008 & 2012
(includes corresponding Graph/Chart) III-58

5. Asia-Pacific III-59
A.Market Analysis III-59
Enzyme Market in China III-59
Product Launch III-59
Strategic Corporate Development III-60
Select Players III-60
Advanced Enzymes Technologies Limited (India) III-60
Biocon Ltd. (India) III-60
B.Market Analytics III-62
Table 95: Asia-Pacific Recent Past, Current & Future
Analysis for Specialty Enzymes by Product Segment -
Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-62

Table 96: Asia-Pacific Long-term Projections for Specialty
Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-63

Table 97: Asia-Pacific 10-Year Perspective for Specialty
Enzymes by Product Segment - Percentage Breakdown of Dollar
Sales for Specialty Medical Enzymes, Polymerases, Nucleases
and Other Enzymes Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-64

Table 98: Asia-Pacific Recent Past, Current & Future
Analysis for Specialty Enzymes by End-Use Segment -
Pharmaceuticals & Diagnostics, Research / Biotechnology and
Others Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-65

Table 99: Asia-Pacific Long-term Projections for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research / Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-65

Table 100: Asia-Pacific 10-Year Perspective for Specialty
Enzymes by End-Use Segment - Percentage Breakdown of Dollar
Sales for Pharmaceuticals & Diagnostics, Research/
Biotechnology and Others Markets for 2003, 2008 & 2012
(includes corresponding Graph/Chart) III-66

6. The Middle East III-67
Market Analysis III-67
Table 101: Middle East Recent Past, Current & Future
Analysis for Specialty Enzymes by Product Segment -
Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-67

Table 102: Middle East Long-term Projections for Specialty
Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-68

Table 103: Middle East 10-Year Perspective for Specialty
Enzymes by Product Segment - Percentage Breakdown of Dollar
Sales for Specialty Medical Enzymes, Polymerases, Nucleases
and Other Enzymes Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-68

Table 104: Middle East Recent Past, Current & Future
Analysis for Specialty Enzymes by End-Use Segment -
Pharmaceuticals & Diagnostics, Research/Biotechnology and
Others Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2010(includes
corresponding Graph/Chart) III-69

Table 105: Middle East Long-term Projections for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-69

Table 106: Middle East 10-Year Perspective for Specialty
Enzymes by End-Use Segment - Percentage Breakdown of Dollar
Sales for Pharmaceuticals & Diagnostics, Research/
Biotechnology and Others Markets for 2003, 2008 & 2012
(includes corresponding Graph/Chart) III-70

7. Latin America III-71
Market Analysis III-71
Table 107: Latin American Recent Past, Current & Future
Analysis for Specialty Enzymes by Product Segment -
Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-71

Table 108: Latin American Long-term Projections for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-72

Table 109: Latin American 10-Year Perspective for Specialty
Enzymes by Product Segment - Percentage Breakdown of Dollar
Sales for Specialty Medical Enzymes, Polymerases, Nucleases
and Other Enzymes Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-72

Table 110: Latin American Recent Past, Current & Future
Analysis for Specialty Enzymes by End-Use Segment -
Pharmaceuticals & Diagnostics, Research/ Biotechnology and
Others Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-73

Table 111: Latin American Long-term Projections for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-73

Table 112: Latin American 10-Year Perspective for Specialty
Enzymes by End-Use Segment - Percentage Breakdown of Dollar
Sales for Pharmaceuticals & Diagnostics, Research/
Biotechnology and Others Markets for 2003, 2008 & 2012
(includes corresponding Graph/Chart) III-74


IV. COMPETITIVE LANDSCAPE